Unknown

Dataset Information

0

Prenatal treatment with rapamycin restores enhanced hippocampal mGluR-LTD and mushroom spine size in a Down's syndrome mouse model.


ABSTRACT: Down syndrome (DS) is the most frequent genetic cause of intellectual disability including hippocampal-dependent memory deficits. We have previously reported hippocampal mTOR (mammalian target of rapamycin) hyperactivation, and related plasticity as well as memory deficits in Ts1Cje mice, a DS experimental model. Here we characterize the proteome of hippocampal synaptoneurosomes (SNs) from these mice, and found a predicted alteration of synaptic plasticity pathways, including long term depression (LTD). Accordingly, mGluR-LTD (metabotropic Glutamate Receptor-LTD) is enhanced in the hippocampus of Ts1Cje mice and this is correlated with an increased proportion of a particular category of mushroom spines in hippocampal pyramidal neurons. Remarkably, prenatal treatment of these mice with rapamycin has a positive pharmacological effect on both phenotypes, supporting the therapeutic potential of rapamycin/rapalogs for DS intellectual disability.

SUBMITTER: Urbano-Gamez JD 

PROVIDER: S-EPMC8152312 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6467217 | biostudies-literature
| S-EPMC3020111 | biostudies-literature
| S-EPMC7809792 | biostudies-literature
| S-SCDT-EMBOJ-2020-105513 | biostudies-other
| S-EPMC6186840 | biostudies-literature
| S-EPMC4559485 | biostudies-literature
| S-EPMC5311935 | biostudies-literature
| S-EPMC4648349 | biostudies-literature
| S-EPMC5009114 | biostudies-literature
| S-EPMC4965035 | biostudies-literature